Kelix bio

Premium
Kelix Bio to acquire five UAE-based pharma entities post Mubadala deal

Healthcare

09 May, 2024

Kelix Bio to acquire five UAE-based pharma entities post Mubadala deal

Kelix Bio, an emerging markets-focused specialty generic biopharmaceutical company is looking to acquire five UAE-based ......

Healthcare

26 March, 2024

Mubadala acquiring Afro-Indian pharma platform in landmark PE exit for DPI, others

Abu Dhabi’s sovereign investor Mubadala Investment Company, which manages assets worth $276 billion in more than 50 ......

Healthcare

16 January, 2025

Kelix bio makes fifth strategic deal since acquisition by Mubadala

Kelix bio, an emerging markets-focused specialty generic biopharmaceutical company has struck its fifth strategic deal ......